Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
4 Future directions Alogliptin presents itself as a promising drug for further development and repurposing for pathological conditions that may or may not be related to T2DM
The studies consistently reflected effects as tissue protection, inflammation control, and vascular stability
10.1139/apnm-2017-0158 Appl Physiol Nutr Metab
The hAMY 3 R cells were cultured in growth medium consisting of DMEM (Gibco, #31966-021) supplemented with 10% v/v FBS (Gibco, #16140-071), 1% v/v Penicillin-Streptomycin (Gibco, #15140-122), 0.5 mg/mL Geneticin G418 (Gibco, #10131-027), 0.4 mg/mL Hygromycin (Invitrogen, #10687010) and 250 nM Methotrexate (Sigma, A6770)
US$ 26.93
US$ 25.21
.jpg)
US$ 22.54
US$ 27.74
US$ 20.21
US$ 20.43
US$ 20.78
US$ 22.77
